We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Oxygen Holds Negligible Benefit for Mild COPD

By HospiMedica International staff writers
Posted on 09 Nov 2016
Print article
Oxygen therapy may not help chronic obstructive pulmonary disease (COPD) patients with moderate desaturation, according to a new study.

Researchers at Johns Hopkins University School of Medicine (Baltimore, MD, USA) conducted a randomized trial involving 738 patients with stable COPD and moderate exercise-induced desaturation. The patients were randomly assigned to receive long-term supplemental oxygen, or not. In the supplemental-oxygen group, patients with resting desaturation were prescribed 24-hour oxygen, while those with moderate desaturation – i.e., only during exercise – were prescribed oxygen during exercise and sleep.

The results, across 42 treatment centers and follow-up of 1-6 years, showed no significant difference between the supplemental-oxygen group and the group without added oxygen in time to death or first hospitalization, nor in total hospitalizations rates, COPD exacerbation rates, and COPD-related hospitalizations. There was no consistent between group differences in measures of quality of life, lung function, and the distance walked in six minutes. The study was published in the October 27, 2016, issue of the New England Journal of Medicine (NEJM).

“The consistency of the null findings strengthens the overall conclusion that long-term supplemental oxygen in patients with stable COPD and resting or exercise-induced moderate desaturation has no benefit with regard to the multiple outcomes measured,” concluded lead author Robert Wise, MD, and colleagues. “Our data support the conclusions of earlier studies that among patients with COPD who have a resting SpO2 of more than 88%, long-term treatment with supplemental oxygen does not result in longer survival than no long-term supplemental oxygen therapy, regardless of whether the patients have exercise-induced desaturation.”

“Since a lack of evidence of effect is not evidence of a lack of any clinical effectiveness, a trial of oxygen use might still be appropriate in selected patients with moderate exertional hypoxemia and intractable breathlessness despite appropriate evidence-based treatment,” commented Magnus Ekström, MD, PhD, of Lund University (Sweden), in an accompanying editorial. “I think that the oxygen treatment should be evaluated by means of blinded exercise tests while the patient is breathing ambient air or oxygen, and discontinued if the patient perceives no benefit during the test or within a day or two after it.”

Two trials that were conducted in the 1970s showed that long-term treatment with supplemental oxygen reduced mortality among patients with chronic obstructive pulmonary disease (COPD) and severe resting hypoxemia. These results led to the recommendation that supplemental oxygen be administered to patients with a SpO2 of less than 89%. In the 1990s, two other trials evaluated the long-term treatment with supplemental oxygen in patients with COPD who had mild-to-moderate daytime hypoxemia; neither trial showed a mortality benefit.

Related Links:
Johns Hopkins University School of Medicine
Lund University
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vein Illuminator
VSI

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.